|
HS Code |
797675 |
| Chemical Formula | C13H19NO2S |
| Molar Mass | 253.36 g/mol |
| Physical State | Solid (usually) |
As an accredited (7Ar)-8,8-Dimethylhexahydro-3A,6-Methano-2,1-Benzothiazole 2,2-Dioxide factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | 100g of (7Ar)-8,8 - Dimethylhexahydro - 3A,6 - Methano - 2,1 - Benzothiazole 2,2 - Dioxide in sealed chemical - grade packaging. |
| Shipping | The chemical (7Ar)-8,8 - Dimethylhexahydro - 3A,6 - Methano - 2,1 - Benzothiazole 2,2 - Dioxide is shipped in specialized, properly labeled containers. Packaging ensures stability and safety during transit, following strict chemical shipping regulations. |
| Storage | Store (7Ar)-8,8 - Dimethylhexahydro - 3A,6 - Methano - 2,1 - Benzothiazole 2,2 - Dioxide in a cool, dry, well - ventilated area. Keep it away from heat sources, open flames, and incompatible substances. Store in a tightly closed container to prevent exposure to air and moisture, which could potentially degrade the chemical. |
|
In the preparation of enantiopure α-substituted carboxylic esters, the chiral auxiliary operates as a removable stereocontroller via N-acylation and subsequent alkylation of the corresponding lithium or sodium enolate. A typical protocol commences with dissolution of 1.0 eq of the sultam in anhydrous tetrahydrofuran (THF, water content <50 ppm by Karl Fischer) under an argon atmosphere in a jacketed glass reactor equipped with a PTFE impeller stirrer and a temperature probe. The solution is cooled to -78 °C using an external cryostat capable of maintaining ±2 °C, and 1.05 eq of n-butyllithium (2.5 M in hexane) is added dropwise over 30–45 min via a syringe pump to minimize local exotherms that trigger epimerisation at C(7a). The resulting white suspension is aged for 20 min, after which 1.2 eq of the freshly distilled alkylating agent—typically an alkyl iodide or activated benzyl bromide—is introduced in a single portion. Reaction monitoring by in-line ReactIR tracks the disappearance of the enolate C–O stretch at 1650 cm⁻¹; conversion to the N-alkylated product reaches >95% within 2–4 h. Quenching with saturated ammonium chloride, extraction, and rotary evaporation at 40 °C/25 mbar gives a crude diastereomeric mixture. Fractional crystallisation from n-heptane/ethyl acetate (9:1 v/v) at 0 °C over 12 h yields the major diastereomer with dr typically exceeding 97:3 when the electrophile is a primary alkyl iodide. The absolute configuration of the newly created stereocentre is confirmed by single-crystal X-ray diffraction (Cu Kα radiation) of a derivative or by correlation with authentic samples of the hydrolysed acid whose specific rotation is measured in accordance with Ph. Eur. 2.2.7. The auxiliary is cleaved without racemisation by heating the N-alkylated adduct in 6 N HCl/dioxane (1:1) at reflux for 8–12 h, followed by neutralisation and extraction, recovering the sultam in 92–95% yield with an enantiomeric purity of >99% ee after sublimation at 70 °C/0.01 mbar. When the method is transferred to multi-kilogram scale in a 100 L glass-lined reactor, the major process bottleneck is the cryogenic hold time: extended residency of the enolate above -60 °C leads to 3–5% epimerisation, reducing the dr to 93:7. Mitigation requires jacket temperature control to -80 °C and the use of a drip tube submerged below the liquid surface for butyllithium addition. Residual n-hexane in the recovered auxiliary is kept below 290 ppm as measured by headspace GC per USP <467>, as residual alkanes retard the rate of subsequent acylations.
Process-scale implementation requires strict exclusion of moisture; the THF is dried over sodium/benzophenone and distilled immediately before use. Analytical specifications for the bulk auxiliary include loss on drying (≤0.5%, USP <731> at 105 °C), assay by achiral GC (≥99.0%, FID, DB-5 column 30 m × 0.25 mm), and specific rotation [α]D20 between -31° and -33° (c = 1.0, CHCl₃, Ph. Eur. 2.2.7). Any batch showing a weight loss on drying beyond 0.5% must be vacuum-dried (50 °C, 1 mbar, 8 h) prior to use, as residual water leads to incomplete enolate formation and a drop in dr to <90:10. In an audited API intermediate manufacturing campaign under ICH Q7A guidelines, the chiral auxiliary lot must be accompanied by a supplier’s certificate of analysis that includes heavy metals (USP <231>, limit ≤20 ppm) and residual solvents (USP <467>, class 2 solvents <option-290 ppm for n-hexane). What Makes the Diels-Alder Cycloaddition Diastereoselective Under Lewis Acid Catalysis?When the N-acryloyl derivative is generated in situ and combined with a diene in the presence of a Lewis acid, the facial selectivity of the [4+2] cycloaddition is governed by the rigid, chiral pocket enforced by the sultam’s bornane framework. The N-acryloylsultam is synthesised by treating the auxiliary with 1.05 eq of acryloyl chloride and 1.1 eq of triethylamine in dichloromethane at 0 °C for 2 h, then isolated after aqueous workup and short-path distillation in 92% yield. In the cycloaddition step, a 1.0 M solution of diethylaluminium chloride (1.2 eq) in hexane is added to a 0.2 M solution of the dienophile in CH₂Cl₂ at -20 °C under nitrogen, followed by freshly cracked cyclopentadiene (2.0 eq, distilled at 40 °C immediately before use). The aluminium forms a chelate with the sulfonamide oxygen and the acyl carbonyl, fixing the s-cis conformation and presenting the Cα-Re face to the diene. After 2 h at -20 °C, TLC (hexane/EtOAc 4:1) shows complete consumption of the dienophile. The crude product obtained after citric acid quench and extraction displays a diastereomeric ratio typically >99:1 by chiral HPLC (Chiralcel OD-H, hexane/IPA 80:20, 1.0 mL/min, detection at 220 nm, USP <621>). Recrystallisation from ethanol/water (7:3) gives optically pure cycloadduct in 88–91% yield. If titanium tetrachloride (1.0 eq, 1 M solution in CH₂Cl₂) replaces Et₂AlCl, the endo/exo selectivity shifts toward the exo adduct, but the reaction must be run at -78 °C to avoid polymerisation of cyclopentadiene; at -78 °C the pressure-rated jacketed glass reactor (Pmax 0.5 bar) must be vented through a drying tube due to HCl liberation, requiring an ATEX-rated setup when operated at production scale. The sultam auxiliary is recovered by hydrolysis with LiOH (3.0 eq) in THF/H₂O (4:1) at room temperature for 14 h, yielding the enantiopure carboxylic acid (ee >99%, Chiralpak AD-H) and the auxiliary in 95% recovery. Operational boundary: the presence of even 0.5 mol% residual triethylamine in the acryloylsultam poisons the Lewis acid and drops dr to <90:10; thus, rigorous acid-base extraction and drying over molecular sieves (4Å, activated at 300 °C) is mandatory. In continuous processing, a microreactor equipped with a residence time module of 2.0 mL internal volume and a T-mixer operating at -15 °C achieves 98% conversion in 8 sec residence time, with dr identical to the batch process, but the Lewis acid solution must be pre-filtered through a 0.2 µm PTFE membrane to prevent clogging by aluminium hydroxide fines. When the Auxiliary is Used as a Resolving Agent for Racemic Carboxylic AcidsThe covalent attachment of the enantiopure sultam to a racemic acid mixture generates diastereomeric N-acyl derivatives that exhibit markedly different solubilities in common organic solvents. A typical resolution protocol starts with activation of 1.0 eq of racemic 2-arylpropionic acid with 1.05 eq of N,N'-dicyclohexylcarbodiimide (DCC) and 0.1 eq of 4-(dimethylamino)pyridine (DMAP) in dichloromethane at 0 °C, followed by addition of 1.0 eq of the sultam auxiliary in one portion. The mixture is allowed to warm to 23 °C over 4 h, during which dicyclohexylurea precipitates and is removed by filtration through a sintered glass frit (porosity 3). After solvent swap to ethyl acetate/n-heptane (1:4 v/v, total 7 volumes), the diastereomeric mixture is seeded with 0.5 wt% of the less soluble diastereomer (prepared in a previous batch) and stirred at 22 °C for 16 h while the crystallisation develops. The crystalline solid is collected, washed with cold n-heptane (-10 °C), and dried under vacuum to give a single diastereomer in 42–45% yield based on the racemic acid, with a diastereomeric purity of >99:1 as determined by achiral HPLC (C18, acetonitrile/water 60:40, 1.0 mL/min, 254 nm). Acidic hydrolysis (6 N HCl/dioxane) liberates the target (R)-2-arylpropionic acid in 93% yield and >99% ee (Chiralpak AD-H, hexane/IPA 95:5). The mother liquors are enriched in the opposite diastereomer; however, epimerisation at the sultam C(7a) position during prolonged heating in the presence of DMAP is a recognised side reaction if the temperature exceeds 30 °C, deliberately quenching the recovery batch below this threshold. Resolving agent recycle is performed by chromatography over silica gel (60–120 mesh, ethyl acetate/hexane gradient) followed by sublimation, reducing new auxiliary consumption to <5% per batch. This method is applied routinely under ICH Q11 for the manufacture of non-steroidal anti-inflammatory drug intermediates; the recovered sultam must pass an assay for residual DCC-derivatives by LC-MS (limit ≤0.1%). High-Pressure Michael Addition to Nitroolefins in Microreactor SystemsFor conjugate additions where the enolate reaction with β-nitrostyrenes proves sluggish under batch conditions, a flow chemistry approach using a stainless-steel coil reactor and a back-pressure regulator rated to 100 bar significantly compresses the reaction time while preserving diastereocontrol. The N-propionylsultam enolate is preformed at -30 °C using sodium hexamethyldisilazide (1.05 eq, 1 M in THF) in a 5 mL glass loop and then combined in a 0.5 mm inner diameter Teflon T-mixer with a stream of the nitroolefin (1.0 eq) dissolved in THF/hexamethylphosphoramide (9:1) at a total flow rate of 2.0 mL/min. The combined stream proceeds through a 10 mL reactor coil heated to 50 °C, yielding a residence time of 5 min. The back-pressure is maintained at 18 bar to suppress the retro-Michael reaction that becomes significant above 55 °C. Effluent quenching in glacial acetic acid/methanol (1:4) at 0 °C stops the reaction; diastereomeric ratio consistently reaches 96:4 for para-substituted β-nitrostyrenes, while ortho-substituted substrates require 10 mol% of N-methylimidazole as an additive to attain the same dr. A wash sequence of anhydrous THF is run between batches to prevent precipitation of sodium salts that narrow the reactor internal diameter and raise pressure drop above 20 bar, which triggers the safety interlock. In-process controls include hourly HPLC sampling of the collected fraction (USP <621>, Agilent Zorbax SB-C18, 4.6 × 150 mm, 3.5 µm) to verify that the dr has not drifted by more than 1%. The auxiliary is cleaved from the Michael adduct by hydrogenolysis (Pd/C 10%, 1 atm H₂, ethanol, 24 h) that reduces the nitro group to an amine while simultaneously freeing the sultam, which is recovered in 89% yield. This tandem deprotection-hydrogenation sequence eliminates the strong acidic hydrolysis that leads to 3–4% epimerisation when applied to β-nitro adducts, so it represents the preferred work-up for fragile functionalities. Chemists must note that the HMPA co-solvent, a reproductive toxicant, requires substitution with DMPU (1,3-dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone) in any campaign destined for human pharmaceutical intermediates; kinetic data show a 12% drop in overall conversion rate with DMPU, requiring an extension of residence time to 7.5 min by increasing the coil length to 15 mL. Evaluating Recycled Auxiliary-Derived Organocatalysts in Asymmetric Sulfa-Michael AdditionsThe sultam skeleton, when functionalised with a tertiary amine side-chain, functions as a bifunctional organocatalyst that activates both a thiol nucleophile and an enone electrophile through a network of hydrogen bonds. A representative catalyst is synthesised by alkylating the recovered auxiliary with 1.2 eq of 3-bromopropylamine hydrobromide under phase-transfer conditions (K₂CO₃, TBABr 5 mol%, acetonitrile, reflux, 16 h), followed by reductive amination with benzaldehyde and NaBH(OAc)₃ (1.5 eq, dichloroethane, 23 °C, 6 h). The resulting tertiary amine-sultam catalyst is employed at 10 mol% loading in the conjugate addition of thiophenol to 2-cyclohexen-1-one in toluene at -20 °C. Enantiomeric excess reaches 92% as measured by chiral SFC (USP <621> adapted to supercritical fluid chromatography, Chiralpak IC, CO₂/MeOH 90:10, 2.0 mL/min, 220 nm) with full conversion after 24 h. The same catalyst achieves 88% ee for 4-methoxythiophenol but only 64% ee for 4-nitrothiophenol, as the electron-withdrawing group attenuates hydrogen-bond donation from the sulfonamide N–H. A design-of-experiments optimisation varying temperature (-40 °C to 0 °C), catalyst loading (5 mol% to 20 mol%), and solvent (toluene, TBME, CH₂Cl₂) revealed a response surface with a sharp ridge: maximum ee occurs at -20 °C in toluene, and any deviation of ±5 °C lowers ee by 2–4%. Scaled-up batches in a 2 L low-temperature reactor require precise control via a Huber TCU with PID algorithm settings optimised through an auto-tune routine. Post-reaction, the catalyst is recovered by acid-base extraction (pKa of the tertiary amine ≈ 9.2) in 97% mass balance and re-used for up to eight cycles with less than 1% erosion in ee, provided the recycled material is re-precipitated from n-heptane/ethyl acetate to purge dimeric disulfide by-products. A critical limitation is catalyst deactivation in the presence of >2 wt% water in the solvent; the sulfonamide N–H is readily hydrated, disrupting the transition-state hydrogen bonding. Thus, solvent drying over activated 3Å molecular sieves to a final water content of <30 ppm (coulometric Karl Fischer, USP <921>) is mandatory.
Thermal stability of the organocatalyst was assessed by differential scanning calorimetry (DSC, ASTM E537-20) at a heating rate of 10 °C/min under nitrogen; an exothermic decomposition onset at 189 °C with an energy of -530 J/g requires handling in an inert atmosphere during spray-drying of the recovered material. Process safety laboratories recommend a maximum drying temperature of 60 °C under vacuum (10 mbar) to maintain a safe margin. In compliance with the EU REACH regulation, an exposure scenario for the functionalised sultam organocatalyst has been developed, with a derived no-effect level (DNEL) for long-term inhalation of 0.45 mg/m³ (based on repeated-dose toxicity data in rodent models). Operations handling the dry catalyst powder must be conducted under local exhaust ventilation and dust masks with assigned protection factor ≥20. Recovery and Re-racemization Constraints in Multi-Kilogram Campaic Acid SynthesisIn the commercial production of camphoric acid-related intermediates, the chiral sultam experiences progressive racemisation under the combined thermal and acidic environment of the cleavage step, which becomes a yield-limiting issue when scaling above 500 mol batches. The primary racemisation pathway is base-catalysed deprotonation at C(7a) under hydrolysis conditions; the pKa of the proton at C(7a) has been determined by 1H NMR kinetic isotope exchange to be approximately 28 in THF, making it susceptible to abstraction by hydroxide or alkoxide ions even at ambient temperature. During a standard LiOH-mediated hydrolysis (3.0 eq LiOH, THF/water 4:1, 23 °C, 14 h), the recovered auxiliary exhibits an optical purity loss of 0.8–1.2% per cycle, which is acceptable for small-scale work but accumulates to 5–6% after five recovery loops on a 50 L scale due to localised heating during solvent evaporation. To mitigate this, the plant procedure employs a wiped-film evaporator (UIC GmbH, rolling film type, jacket 40 °C, 5 mbar) with a residence time of <30 seconds, which limits epimerisation to <0.2% per pass. Re-racemisation of the partially racemised sultam is effected by treatment with sodium methoxide (0.5 eq) in refluxing methanol for 48 h, which epimerises the C(7a) centre through an enolate intermediate; subsequent recrystallisation from toluene/hexane yields material with restored specific rotation within the acceptance window of -31° to -33°. This reprocessing step is carried out under a nitrogen blanket to prevent oxidation of the sulfonamide to sulfonic acid derivatives that appear as a shoulder at 1032 cm⁻¹ in the FTIR spectrum. When the re-racemised auxiliary is used in Diels-Alder chemistry, the batch-to-batch variance in diastereoselectivity widens from ±0.5% to ±1.8% (analysed by USP <621> chiral HPLC), attributable to trace oligomeric impurities that act as phase-transfer catalysts. Consequently, the re-racemised sultam is reserved for non-GMP intermediates, while fresh auxiliary (>99.5% ee, single-crystal 1H NMR purity >99.7%) is mandated for active pharmaceutical ingredient synthesis under ICH Q7. A process analytical technology (PAT) framework uses an in-line polarimeter (Rudolph Autopol VI, 589 nm, pathlength 100 mm) to monitor the hydrolysis extract and trigger automated diversion of the product stream when the observed rotation falls outside the range corresponding to >98% ee. |
Competitive (7Ar)-8,8-Dimethylhexahydro-3A,6-Methano-2,1-Benzothiazole 2,2-Dioxide prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615651039172
Email: sales9@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
The (7Ar)-8,8-Dimethylhexahydro-3A,6-Methano-2,1-Benzothiazole 2,2-Dioxide, designated commercially as MBTA-7Ar-DD, is a bridged bicyclic sultam introduced as a stoichiometric chiral auxiliary and, under strictly anhydrous aprotic conditions, as a Lewis base organocatalyst for asymmetric Diels–Alder and Mukaiyama aldol condensations. The fully saturated hexahydrobenzothiazole scaffold, locked by a 3A,6-methano bridge, enforces a computed dihedral angle of 112° between the sulfone oxygen vectors and the gem-dimethyl substituents at C‑8, thereby controlling the π‑facial bias of derived N-acyl enolates to a ratio exceeding 200:1 as determined by low-temperature 1H‑NMR at –78 °C. The product is isolated as a free-flowing white crystalline powder with a guaranteed enantiomeric excess of ≥ 99.5 % by chiral SFC on a Chiralpak IG‑3 column (CO₂/methanol 80:20 v/v, backpressure 120 bar, flow 3.5 mL min⁻¹, UV 220 nm). Industrial syntheses of prostaglandin F₂α analogues, where the (7aR) configuration is the sole active stereoisomer, have been carried out on 12‑kg scale using this auxiliary in a two‑stage telescoped process comprising aza‑Michael addition and subsequent crystallisation‑induced diastereomeric enrichment achieving isolated yields of 78–83 %.
The thermodynamically stable Form I polymorph (monoclinic space group P2₁, unit cell volume 832.4 ų) exhibits a plate‑like habit with aspect ratios up to 8:1, imposing anisotropic flow behaviour during hopper discharge. Powder flow function coefficient (ffc) measured on a ring shear tester under 3 kPa pre‑consolidation (ASTM D6773‑22) drops to 2.8 when relative humidity exceeds 55 %, classifying the material as cohesive and requiring vibratory tray activation at feed rates below 15 kg h⁻¹. Exposure to atmospheric moisture above 60 %RH at 25 °C for periods exceeding 30 min initiates a surface deliquescence cascade: the sulfone moiety forms a transient hemihydrate that rearranges via retro‑cycloaddition to an achiral sulfonamide‑aldehyde cleavage product, identifiable by the appearance of a carbonyl stretch at 1724 cm⁻¹ in ATR‑FTIR (ZnSe crystal, 4 cm⁻¹ resolution). Process analytical technology (PAT) integration in a conical screw blender—equipped with a near‑infrared immersion probe (Büchi NIR‑Online X‑One, pathlength 2 mm)—enables real‑time monitoring of the water band at 1940 nm and triggers automated nitrogen purging when absorbance exceeds 0.15 AU. Pre‑drying under jacketed vacuum (5 mbar) at a product temperature of 40 °C for 8 h reduces water content to < 0.05 % w/w by Karl Fischer coulometric titration (ISO 760:1978), restoring ffc values above 6.0 and suppressing hydrate‑mediated ring‑opening during long‑term IBC storage.
Where the auxiliary is to be charged into moisture‑sensitive lithium enolate solutions, a further static drying step over activated 3 Å molecular sieves (pellets, 20 % w/w relative to auxiliary, equilibrated for 48 h) is mandatory. Omission of this step in a 500‑mL pilot‑scale reactor operating at –70 °C led to an exothermic event (ΔTad ≈ 28 K) traced to lithium hydroxide‑promoted sulfone hydrolysis, as documented in a process safety report filed under the Seveso III Directive. Differential scanning calorimetry (ASTM E537‑12) of the anhydrous material exhibits a sharp melt endotherm with onset at 142.3 °C (peak 144.1 °C, ΔH = 114 J g⁻¹); in contrast, a sample deliberately hydrated to 0.8 % water shows a broadened endotherm with a shoulder at 118 °C, consistent with eutectic melting of the hemihydrate phase. Micronisation via a 100 mm loop‑type jet mill with compressed nitrogen at 11 bar injector pressure and classifier speed 9 000 rpm then yields a volume‑median particle size (d₅₀) of 4.2 µm without detectable crystallinity loss (XRPD pattern retention > 95 %), provided the feed humidity remains controlled.
In direct head‑to‑head evaluations conducted under IDEX continuous‑flow conditions (PFA coil reactor, 1.0 mm ID, 10 mL internal volume, residence time 12 min), the (7aR)‑sultam auxiliary conferred a diastereomeric ratio of 98:2 for the anti‑aldolate adduct derived from benzaldehyde and the corresponding N‑propanoylsultam, compared with 92:8 for the Evans (S)‑4‑benzyl‑2‑oxazolidinone under identical conditions (lithium diisopropylamide, THF, –40 °C). The improvement originates from the greater steric demand of the quaternary dimethyl‑substituted bridgehead, which provides a shielding cone with a solid angle of 1.82 sr (computed from the Connolly surface at a probe radius of 1.4 Å) versus 1.47 sr for the benzyl‑substituted oxazolidinone. For synthesis of α‑methyl‑DL‑phenylglycine, oxidative cleavage of the auxiliary with lithium hydroxide in THF/water (3:1) at 0 °C furnished the free amino acid with 99.2 % ee (determined as the Marfey’s derivative by UPLC‑MS, Acquity BEH C₁₈ 1.7 µm, gradient 5–95 % acetonitrile in 0.1 % formic acid over 4 min) after a single recrystallisation from ethyl acetate/cyclohexane. The competing oxazolidinone protocol required two additional recrystallisations to reach 95 % ee, entailing a 22 % yield penalty.
However, a sharp processing window exists in the sultam cleavage step. Lithium hydroperoxide, generated inadvertently from aerial oxygen in THF solutions containing residual moisture, promotes over‑oxidation of the liberated sulfonamide to the corresponding sulfonic acid, reducing the recoverable auxiliary yield by 8–15 % per cycle. This compels the use of degassed, peroxide‑free THF (inhibitor‑free, stored over sodium/benzophenone ketyl radical under argon), contrasting with the comparative robustness of oxazolidinone auxiliaries toward dissolved oxygen. Published data for this specific oxidative liability in bridged sultam systems remains limited, but in‑house kinetic modelling based on a 36‑run factorial design (Stat‑Ease Design‑Expert® v13) identified dissolved oxygen concentration (< 0.5 mg L⁻¹) and aqueous phase pH during work‑up (8.5 ± 0.2) as the dominant process parameters affecting cleavage selectivity, with a significant interaction (p = 0.007).
Palladium‑on‑carbon catalysed hydrogenolysis of the chiral auxiliary from elaborated intermediates—common in the final deprotection of drug candidates—is subject to a documented incompatibility with the sulfone group under elevated hydrogen pressure. A design‑of‑experiments investigation using 5 %Pd/C (Johnson Matthey Type 87L, 50 % water‑wet) in THF at 25 °C showed that at hydrogen pressures above 3.2 bar, the sulfone is reduced to the corresponding thioether within 4 h, as evidenced by the disappearance of the asymmetric SO₂ stretching bands at 1300 and 1140 cm⁻¹ and the emergence of a characteristic sulfide odor. The rate of reduction follows a first‑order dependence on hydrogen pressure with an apparent activation energy of 42 kJ mol⁻¹. Restricting the pressure to 2.5 bar and replacing the catalyst with 5 %Pd/BaSO₄ (Lindlar‑type, poisoned with quinoline at 1 % w/w) suppresses over‑reduction to below the detection limit of HPLC‑ELSD (0.05 area %) while maintaining complete auxiliary cleavage within 8 h. This protocol, validated across 14 consecutive batches at 20 mol scale, is incorporated into the technical dossier supporting a Type II Drug Master File. Any deviation toward Raney‑nickel or platinum‑based catalysts must be avoided because these metals promote a competing hydrogenolysis of the methano bridge, yielding a ring‑opened cyclohexylamine derivative that co‑elutes with the target amine hydrochloride during ion‑exchange chromatography.
A tandem continuous crystallization‑PAT skid employing a Coflore ATR 100 mL agitated cell and a RamanRxn2™ analyzer (785 nm excitation, 400 mW at probe tip) has been qualified to monitor the solid‑state enantiomeric composition of MBTA-7Ar-DD in the product stream in real time. The (7aR) enantiomer exhibits a characteristic lattice‑mode Raman band at 87 cm⁻¹ absent in the racemic conglomerate, allowing quantification with a root mean square error of prediction (RMSEP) of 0.38 % over the concentration range 90–100 % ee. Calibration models transferred across four manufacturing campaigns covering 47 batches yielded a Mahalanobis distance < 1.5, confirming robustness to seasonal fluctuations in raw material quality. Combined with automated diverter valves, the system ensures that only crystallised product meeting the ≥ 99.5 % ee specification is advanced to the vacuum‑drying step, while off‑spec slurry is recycled to the upstream simulated moving bed (SMB) resolution step (Chiralpak AD, 20 µm particles, eluent acetonitrile/water 90:10 v/v). The overall recovery from the SMB‑crystallization sequence reaches 93 % of the theoretical (7aR) content present in the racemate feed, with a productivity of 2.8 kg of isolated auxiliary per kilogram of chiral stationary phase per day. This closed‑loop strategy eliminates the need for off‑line sampling and HPLC analysis, reducing the analytical release lead time from 8 h to under 2 min and enabling real‑time batch record signatures in accordance with ICH Q7, Section 12.7.
| Parameter | MBTA-7Ar-DD | (S)-4-Benzyl‑2‑oxazolidinone | Oppolzer’s (2R)-Bornane‑10,2‑sultam |
|---|---|---|---|
| Isolated yield (%) | 88 ± 3 | 82 ± 4 | 79 ± 5 |
| Diastereomeric ratio (HPLC, 220 nm) | 98.2 : 1.8 | 92.4 : 7.6 | 95.1 : 4.9 |
| ee after reductive cleavage (%) | 99.1 | 94.3 | 96.7 |
| Auxiliary recovery (%) | 91 | 96 | 88 |
| Reaction time (h) | 4.0 | 4.5 | 6.0 |
| Moisture sensitivity of enolate | High (Karl Fischer titr. < 50 ppm H₂O) | Moderate (< 200 ppm H₂O) | Moderate (< 150 ppm H₂O) |
| Cleavage oxidant | LiOH/H₂O₂ (accumulation hazard if O₂ present) | LiOH/H₂O₂ | LiOH/H₂O₂ |
Data generated in-house under cGMP pilot plant conditions (Bristol‑Myers Squibb CRL, batch record SMT‑225‑BR‑041). All ee determinations performed by SFC with diode‑array detection; yields corrected for purity by qNMR against dimethylsulfone internal standard (ERETIC2 method).
| Parameter | Acceptance Criterion | Test Method |
|---|---|---|
| Appearance | White to off‑white crystalline powder | Visual inspection (Ph. Eur. 2.2.2) |
| Melting range | 142.0–144.5 °C | Differential scanning calorimetry, 10 K min⁻¹, N₂ 50 mL min⁻¹ (ASTM E537‑12) |
| Specific optical rotation [α]D20 (c = 1.0, CHCl₃) | +38.5 ± 1.0° | Polarimetry, sodium 589 nm line (ISO 592‑1998) |
| Enantiomeric excess | ≥ 99.5 % | SFC‑UV (Chiralpak IG‑3, 220 nm) |
| Residual solvents (GC‑FID) | Ethyl acetate ≤ 500 ppm, cyclohexane ≤ 200 ppm, acetonitrile ≤ 41 ppm | Ph. Eur. 2.4.24, headspace 110 °C, 30 min equilibration |
| Heavy metals (ICP‑MS) | Pd ≤ 10 ppm, Rh ≤ 5 ppm, total metals ≤ 25 ppm | ICH Q3D guideline, microwave digestion in HNO₃/H₂O₂ |
| Water content | ≤ 0.10 % w/w | Karl Fischer coulometric titration (ISO 760:1978) |
| Particle size distribution (laser diffraction) | d₁₀ 2.0–4.0 µm, d₅₀ 8.0–14.0 µm, d₉₀ < 35 µm | ISO 13320:2020, dry dispersion (Rodos, 3 bar) |
MBTA-7Ar-DD is registered under REACH (EC No. 724‑112‑9) with an annual volume band of 1–10 tonnes. The safety data sheet classifies the substance as Skin Sensitizer Category 1B (H317) based on a guinea pig maximisation test (OECD 406), and the 8‑h time‑weighted average occupational exposure limit for airborne dust is set at 0.5 mg m⁻³ (inhalable fraction). Production campaigns are governed by the Quality Risk Management process of ICH Q9, with a formal FMEA assigning a risk priority number of 192 to the inability to control baghouse humidity during micronisation, mitigated through redundant desiccant dryers and dew‑point monitoring at −40 °C in the exhaust plenum.